
Soluble Tim-3 serves as a tumor prognostic marker and …
2024年8月20日 · Resistance to PD-1 blockade in onco-immunotherapy greatly limits its clinical application. T cell immunoglobulin and mucin domain containing-3 (Tim-3), a promising immune checkpoint target, is cleaved by ADAM10/17 to produce its soluble form (sTim-3) in humans, potentially becoming involved in anti-PD-1 resistance.
火热的免疫检查点——TIM3靶点 - 知乎
TIM-3(T cell immunoglobulin domain and mucin domain-3) T 淋巴细胞免疫球蛋白黏蛋白 3,是一种活化诱导的抑制性分子,参与慢性病毒感染和癌症的免疫耐受和 T 细胞衰竭。 通过与 CD66a 形成异二聚体相互作用,促进 TIM3 成熟和细胞表面表达。 在小鼠结直肠癌模型中,共同阻断 CD66a 和 TIM3 可增强抗肿瘤免疫应答,并消除肿瘤。 图2 TIM3介导的细胞免疫耐受. 目前抗 PD-1 或抗 PD-L1 抗体与抗TIM3抗体联用是肿瘤免疫治疗的火热靶点。 蛋白表达分析. 利用流式细 …
Tim-3: A co-receptor with diverse roles in T cell exhaustion and ...
2019年4月1日 · Tim-3 is characterized by 1) a conserved extracellular IgV domain with N-linked glycosylation sites, and a mucin-like stalk that contains O-linked glycosylation sites; 2) a transmembrane domain; and 3) an intracellular cytoplasmic tail with 5 tyrosines.
Long non-coding RNA Lnc-Tim3 exacerbates CD8 T cell …
2018年4月30日 · Here, we show that Lnc-Tim3 is upregulated and negatively correlates with IFN-γ and IL-2 production in tumor-infiltrating CD8 T cells of HCC patients. Lnc-Tim3 plays a pivotal role in...
TIM-3 restrains anti-tumour immunity by regulating inflammasome ...
Here, using conditional knockouts of TIM-3 together with single-cell RNA sequencing, we demonstrate the singular importance of TIM-3 on dendritic cells (DCs), whereby loss of TIM-3 on DCs-but not on CD4 + or CD8 + T cells-promotes strong anti-tumour immunity.
Targeted knockdown of Tim3 by short hairpin RNAs improves the function ...
This study was aimed to evaluate the effects of targeted-knockdown of Tim3 on the antitumor function of anti-mesothelin (MSLN)-CAR T cells. To knockdown Tim3 expression, three different shRNA sequences specific to different segments of the human Tim3 gene were designed and co-inserted with an anti-MSLN-CAR transgene into lentiviral vectors.
TIM3 Expression in Anaplastic-Thyroid-Cancer-Infiltrating …
Our studies show that TIM3 is a newly identified immune checkpoint in macrophages. Since TIM3 is known as a negative immune regulator, it should be considered as a promising immunotherapeutic target for ATC. Keywords: anaplastic thyroid cancer, tumor-associated macrophages, M2-like macrophage polarization, TIM3, immunotherapy 1. Introduction
Downregulation of TIM-3 mRNA expression in peripheral blood ... - PubMed
Our results suggest that below-normal expression of TIM-3 mRNA in PBMC may be involved in the pathogenesis of SLE. The T-cell immunoglobulin and mucin domain (TIM) family is associated with autoimmune diseases, but its expression level in the immune cells of systemic lupus erythematosus (SLE) patients is not known.
Study on Tim3 Regulation of Multiple Myeloma Cell Proliferation
2020年11月19日 · We found that the relative mRNA and protein expression NF-κB signal pathway (PI3K, AKT, mTOR, NF-κB) decreased ( p <0.05) with down-regulation Tim3 of MM cells, suggesting that Tim3 may be a potential therapeutic target.
膜型、可溶性Tim-3在抗肿瘤免疫应答中的作用及肿瘤基因治疗的 …
Tim-3 (T-cell immunoglobulin-and mucin-domain-containg molecule)分子的发现是源于寻找区分T_H1细胞和T_H2细胞的表面标志物.对其功能的研究揭示Tim-3在自身免疫性疾病和器官移植排斥反应性疾病中具有重要的免疫学作用.应用Tim-3的抗体和Tim-3-Ig融合蛋白能够影响免疫反应,加速 ...